Atropine for the Treatment of Childhood Myopia in India: Multicentric Randomized Trial

This multicentric, double-blinded, placebo-controlled, randomized clinical trial reports 1-year data proving efficacy of 0.01% atropine drops in reducing myopia progression (spherical equivalent [SE]) in Indian children having mild to moderate myopia without any significant effect on axial length (AL) elongation.